Affidea offers integrated and reliable services in the early diagnosis and treatment of the long-COVID syndrome, for the return of citizens to their activities safely and without stress.
Based on the definition of the World Health Organization, the “long-COVID” syndrome can affect people with a history of possible or confirmed infection with SARS-CoV-2, usually 3 months after the onset of the disease of COVID-19, while it involves symptoms lasting at least 2 months and cannot be explained by any other reason. The most common symptoms of the “long–COVID” syndrome include fatigue, shortness of breath, and cognitive dysfunction, and they appear to have a significant impact on patients’ daily functioning. Affidea Group’s structured approach helps minimize the impact of long-COVID syndrome, with the monitoring program including laboratory and imaging tests.
Specifically, during a visit to the Affidea diagnostic centers, the following tests are carried out, without waiting for the examinee, under conditions of complete security.
Post-Covid Check-Up at a special price
The laboratory test package is offered at the special price of €95 and includes: General Blood, Electrolytes (Potassium, Sodium), Creatinine, Urea, General Urinary, CPK, CK-MB Liver Function: SGOT, SGPT, γ-GT, ALP, CRP, TKE, Ferritin, TSH, FT4, VitD, Diabetes, Troponin, D-Dimers, Glycosylated Hemoglobin.
The package of imaging tests at the special price of €70 includes: Chest X-ray, Electrocardiogram, Heart Triplex, Cardiological assessment.
The above special test packages, adapted to the long-term effects of COVID-19, combined, constitute a comprehensive health check, after contracting the coronavirus, and are offered together at the special price of €150.
Safe and effective rehabilitation of long-COVID patients is a fundamental part of recovery, as 1 in 10 will develop symptoms for a period of 12 weeks or longer. Given the significant number of patients with COVID-19, the goal of preventive health checks is to assess and treat symptoms, early diagnosis of complications of the disease and reduce its long-term complications. Affidea, since 2005, offers highly reliable health services, investing in innovation and cutting-edge technology. Giving particular importance and priority to the human being, it applies procedures aimed at safeguarding the safety of the examinees and at the same time ensuring the best possible medical result.